Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV
about
Highly Successful Hepatitis C Virus (HCV) Treatment Outcomes in Human Immunodeficiency Virus/HCV-Coinfected Patients at a Large, Urban, Ryan White Clinic.Pharmacokinetics of the New Hepatitis C Virus NS3 Protease Inhibitor Narlaprevir following Single-Dose Use with or without Ritonavir in Patients with Liver Cirrhosis.Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.Drug interactions in HIV-infected patients treated for hepatitis C.Treatment of hepatitis C with new fixed dose combinations.How I treat hepatitis C virus infection in patients with hematologic malignancies.A review of drug-drug interactions in older HIV-infected patients.Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disordersDiagnosis and Management of Hepatitis C Infection in Primary Care Settings.Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world.
P2860
Q33647154-E8144B1C-9FE5-4470-BAAE-F6F884D20972Q37428608-BFA9AD73-DFFD-452C-9B70-6E9583989414Q38753617-80E414A2-2AAD-4500-8973-DCC224C89982Q40143109-425E29A0-3C47-4583-8441-251CCF4EF1AEQ40148071-191BFB5D-4A48-445D-A2F3-B47EF6368EDEQ40604797-7E4D2C3A-C812-44EB-8408-F2F36A52769DQ41996857-04998B2F-04F6-44C8-A00C-B521B0ADF94DQ42680423-43D5C452-836F-44D7-A873-30C50B4DA8BEQ47551020-D067068A-E357-4F63-B1C0-CE559CF23EFEQ50140688-29C4D7D2-1BC8-4D65-9C53-C61638E61A71
P2860
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV
@en
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
@nl
type
label
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV
@en
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
@nl
prefLabel
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV
@en
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
@nl
P2860
P356
P1476
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV
@en
P2093
Christine E MacBrayne
Jennifer J Kiser
P2860
P304
P356
10.1093/CID/CIW220
P407
P478
63 Suppl 1
P577
2016-07-01T00:00:00Z